Skip to main content

68th Annual Scientific Meeting Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Red Recording

Sig Meeting

Aaron Jenkins, PhD

Director, Health Economics & Outcomes Research, Migraine
Pfizer R&D UK Ltd, Tadworth, Surrey, UK

Poster(s):

(E 64) Patient-reported outcomes (PROs) for patients prescribed only acute or preventive rimegepant for migraine care via telemedicine at initial consultation and quarterly check-in
(T 95) A post-hoc assessment of the impact of headache-free interictal period duration and every other day treatment with rimegepant on quality of life scores in a 12-week randomized placebo-controlled trial of migraine prevention